BioInfra Co., Ltd. (KOSDAQ:199730)

BioInfra Statistics

Total Valuation

BioInfra has a market cap or net worth of KRW 22.57 billion. The enterprise value is 24.63 billion.

Market Cap	22.57B
Enterprise Value	24.63B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	Dec 29, 2025

Share Statistics

BioInfra has 4.86 million shares outstanding. The number of shares has decreased by -0.38% in one year.

Current Share Class	4.86M
Shares Outstanding	4.86M
Shares Change (YoY)	-0.38%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	51.53%
Owned by Institutions (%)	n/a
Float	2.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.92
PB Ratio	1.01
P/TBV Ratio	1.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.35
EV / Sales	1.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.41

Financial Position

The company has a current ratio of 0.83, with a Debt / Equity ratio of 0.53.

Current Ratio	0.83
Quick Ratio	0.75
Debt / Equity	0.53
Debt / EBITDA	n/a
Debt / FCF	-6.44
Interest Coverage	-15.94

Financial Efficiency

Return on equity (ROE) is -17.97% and return on invested capital (ROIC) is -9.87%.

Return on Equity (ROE)	-17.97%
Return on Assets (ROA)	-8.61%
Return on Invested Capital (ROIC)	-9.87%
Return on Capital Employed (ROCE)	-25.08%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.60
Inventory Turnover	n/a

Taxes

Income Tax	-1.82B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.39% in the last 52 weeks. The beta is 0.71, so BioInfra's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	-31.39%
50-Day Moving Average	4,970.80
200-Day Moving Average	5,556.95
Relative Strength Index (RSI)	40.51
Average Volume (20 Days)	8,392

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioInfra had revenue of KRW 24.47 billion and -4.60 billion in losses. Loss per share was -946.41.

Revenue	24.47B
Gross Profit	5.29B
Operating Income	-5.63B
Pretax Income	-6.43B
Net Income	-4.60B
EBITDA	-2.23B
EBIT	-5.63B
Loss Per Share	-946.41

Balance Sheet

The company has 9.76 billion in cash and 11.82 billion in debt, giving a net cash position of -2.06 billion or -423.64 per share.

Cash & Cash Equivalents	9.76B
Total Debt	11.82B
Net Cash	-2.06B
Net Cash Per Share	-423.64
Equity (Book Value)	22.28B
Book Value Per Share	4,581.24
Working Capital	-2.68B

Cash Flow

In the last 12 months, operating cash flow was -1.39 billion and capital expenditures -451.35 million, giving a free cash flow of -1.84 billion.

Operating Cash Flow	-1.39B
Capital Expenditures	-451.35M
Free Cash Flow	-1.84B
FCF Per Share	-377.58

Margins

Gross margin is 21.60%, with operating and profit margins of -23.00% and -18.81%.

Gross Margin	21.60%
Operating Margin	-23.00%
Pretax Margin	-26.26%
Profit Margin	-18.81%
EBITDA Margin	-9.11%
EBIT Margin	-23.00%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 400.00, which amounts to a dividend yield of 8.41%.

Dividend Per Share	400.00
Dividend Yield	8.41%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.38%
Shareholder Yield	8.79%
Earnings Yield	-20.40%
FCF Yield	-8.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioInfra has an Altman Z-Score of 1.51 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.51
Piotroski F-Score	2